Stockscreener 앱 받기
177.18
1.21%
1.97
전일 마감가:
$175.21
열려 있는:
$175.27
하루 거래량:
135.14K
Relative Volume:
0.11
시가총액:
$14.31B
수익:
$8.19B
순이익/손실:
$758.19M
주가수익비율:
19.30
EPS:
9.18
순현금흐름:
$1.06B
1주 성능:
+1.27%
1개월 성능:
-0.69%
6개월 성능:
-4.67%
1년 성능:
-41.37%
1일 변동 폭
$174.62
$178.62
1주일 범위
$170.27
$178.62
52주 변동 폭
$125.10
$310.54
Icon Plc Stock (ICLR) Company Profile
ICLR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
177.23 | 13.63B | 8.19B | 758.19M | 1.06B | 9.18 |
|
TMO
Thermo Fisher Scientific Inc
|
476.95 | 178.47B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
194.46 | 138.15B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
645.71 | 51.27B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
127.87 | 35.93B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
188.72 | 31.74B | 15.70B | 1.24B | 2.01B | 6.91 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-09 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-09-03 | 업그레이드 | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-07-24 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-04-14 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-03-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2024-10-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | 개시 | Redburn Atlantic | Neutral |
| 2024-09-18 | 개시 | Leerink Partners | Outperform |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2023-12-15 | 개시 | Truist | Buy |
| 2023-09-13 | 개시 | TD Cowen | Outperform |
| 2023-01-17 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-01-13 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-11-09 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-09-07 | 개시 | UBS | Buy |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-05-24 | 개시 | Guggenheim | Buy |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2021-09-27 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-23 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-14 | 개시 | Citigroup | Neutral |
| 2021-04-13 | 재개 | BofA Securities | Neutral |
| 2021-04-01 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | 개시 | Barclays | Equal Weight |
| 2021-03-01 | 업그레이드 | UBS | Neutral → Buy |
| 2021-02-26 | 업그레이드 | Truist | Hold → Buy |
| 2020-07-24 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-04-20 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-03-02 | 개시 | Deutsche Bank | Hold |
| 2020-01-27 | 다운그레이드 | SunTrust | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-09-23 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | 업그레이드 | UBS | Sell → Neutral |
| 2019-01-25 | 업그레이드 | Mizuho | Neutral → Buy |
| 2018-10-26 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-10-09 | 개시 | UBS | Sell |
| 2018-04-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2018-02-15 | 재확인 | Mizuho | Neutral |
| 2018-01-19 | 개시 | Evercore ISI | Outperform |
| 2017-10-27 | 재확인 | Barclays | Equal Weight |
| 2017-09-11 | 개시 | BofA/Merrill | Buy |
| 2017-07-31 | 업그레이드 | SunTrust | Hold → Buy |
| 2017-07-27 | 재확인 | Mizuho | Neutral |
| 2017-06-29 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
Icon Plc 주식(ICLR)의 최신 뉴스
Icon Plc $ICLR Shares Bought by Financiere des Professionnels Fonds d investissement inc. - MarketBeat
LVM Capital Management Ltd. MI Reduces Holdings in Icon Plc $ICLR - MarketBeat
Mizuho Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $225 - 富途牛牛
Goldman Sachs Group Inc. Sells 106,606 Shares of Icon Plc $ICLR - MarketBeat
17,633 Shares in ICON PLC $ICLR Acquired by Greenhaven Associates Inc. - MarketBeat
Did ICON’s (ICLR) Internal CEO Succession Signal Strategic Continuity or Missed Opportunity for Change? - simplywall.st
Jefferies rates IQVIA, Charles River as Buy, ICON as Hold - MSN
Brokerages Set Icon Plc (NASDAQ:ICLR) PT at $219.64 - MarketBeat
Jefferies Downgrades ICON Public Limited (ICLR) to Hold From Buy - Insider Monkey
TD Cowen Maintains Icon PLC(ICLR.US) With Hold Rating, Cuts Target Price to $183 - 富途牛牛
Baird Financial Group Inc. Cuts Holdings in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR): Assessing Valuation as CEO Transition Confirms Stability and 2025 Guidance - simplywall.st
Jefferies Downgrades Icon PLC(ICLR.US) to Hold Rating, Cuts Target Price to $175 - 富途牛牛
ICON Plc and Zealand Pharma’s Petrelintide Study: A Key Update for Investors - TipRanks
ICON plc’s Latest Study on Kedrion IVIG 10% for Chronic ITP: A Market Perspective - TipRanks
Will ICON’s (ICLR) Leadership Transition Reinforce Operational Continuity or Signal a Strategic Shift? - simplywall.st
Truist Financial Reaffirms Their Buy Rating on Icon (ICLR) - The Globe and Mail
A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $220 to $225 - 富途牛牛
ICON plc Reaffirms 2025 Financial Guidance Amid CEO Transition - The Globe and Mail
Icon CEO Steve Cutler to retire, Barry Balfe to succeed - TipRanks
ICON Announces CEO Transition: Dr. Steve Cutler to Retire, Barry Balfe to Take Over - AInvest
ICON plc Announces CEO Changes, Effective October 1, 2025 - MarketScreener
ICON plc Appoints Barry Balfe to the Board - MarketScreener
ICON's Leadership Transition and Market Implications: Succession Strategy and Operational Continuity in Growth-Stage Biotech Firms - AInvest
ICON names Barry Balfe as new CEO effective October 1 By Investing.com - Investing.com Australia
Icon CEO Steve Cutler to Retire; Barry Balfe to Take Reins - MarketScreener
ICON names Barry Balfe as new CEO effective October 1 - Investing.com
ICON Promotes Barry Balfe to CEO Position - AInvest
Icon Promotes COO Barry Balfe to CEO Role - MarketScreener
ICON Announces CEO Transition Effective October 1, 2025 - TipRanks
ICON Announces CEO Transition - FinancialContent
ICON’s Strategic Positioning in the Evolving CRO Landscape - AInvest
ICON plc Announces Participation in September 2025 Investor Conferences - The Globe and Mail
Baird Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $224 - 富途牛牛
Healthcare Stocks to Watch: argenx, ICON, and Edwards Lifesciences with Long-Term Potential - AInvest
ICON plc to Participate at Upcoming Investor Conferences - PharmiWeb.com
ICON plc to Participate at Upcoming September 2025 Investor Conferences - BioSpace
ICON plc Announces Participation in Upcoming Investor Conferences - AInvest
ICON’s SWOT analysis: stock outlook amid industry headwinds and opportunities - Investing.com
Icon (ICLR) Stock Price, News & Analysis - MarketBeat
ICON’s Interim Financials Prompt Fresh Questions About Operational Agility and Efficiency for ICLR Investors - Yahoo Finance
Does ICON’s (ICLR) Interim Update Reveal New Clues About Efficiency in Clinical Research Outsourcing? - simplywall.st
ICON plc Releases Interim Financial Statements for 2025 - The Globe and Mail
AstraZeneca and Icon Plc’s Study on ATTR Amyloidosis: Key Insights for Investors - TipRanks
ICON Properties Plc (Malawi) declared a final dividend of 0.15 MWK per share - AfricanFinancials
Icon Plc (ICLR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.78%
자본화:
|
볼륨(24시간):